No, leukemia is not an autoimmune disease. Leukemia is a cancer — a malignancy of blood-forming cells in the bone marrow. Autoimmune diseases, by contrast, occur when the immune system mistakenly attacks the body’s own healthy tissues. These are fundamentally different processes. But the reason this question comes up so often is that leukemia and autoimmune diseases share a surprisingly tangled relationship: leukemia can cause autoimmune phenomena, autoimmune diseases can mimic leukemia, and in rare cases, chronic autoimmune conditions may even slightly increase the risk of developing certain leukemias.
So while the short answer is straightforward, the full picture is far more nuanced. If you’re asking “is leukemia an autoimmune disease” because you or someone you know has overlapping symptoms — unexplained cytopenias, joint pain, recurrent fevers — this article will help you understand where these two worlds collide and what to do next.
Leukemia vs. Autoimmune Disease: What’s Actually Different?
At the cellular level, leukemia and autoimmune diseases couldn’t be more distinct. Leukemia involves the uncontrolled clonal expansion of abnormal white blood cells — essentially, one rogue cell acquires genetic mutations and starts multiplying relentlessly. Autoimmune diseases involve structurally normal immune cells that are functionally misdirected, attacking healthy tissue as if it were foreign.
| Feature | Leukemia | Autoimmune Disease |
|---|---|---|
| Core problem | Malignant clonal expansion of blood cells | Immune system attacks self-tissues |
| Cell behavior | Abnormal, cancerous cells proliferate | Normal cells target wrong tissues |
| Bone marrow | Infiltrated by malignant blasts or clonal cells | Usually normal or reactive |
| Genetic driver | Somatic mutations (e.g., BCR-ABL, FLT3) | HLA associations, polygenic susceptibility |
| Treatment approach | Chemotherapy, targeted therapy, transplant | Immunosuppression, biologics |
| Example | Chronic lymphocytic leukemia (CLL) | Systemic lupus erythematosus (SLE) |
Why Leukemia Can Look Like an Autoimmune Disease
Here’s where things get clinically interesting. Several types of leukemia — particularly chronic lymphocytic leukemia (CLL) — frequently produce autoimmune complications. In fact, roughly 5–10% of CLL patients develop autoimmune hemolytic anemia (AIHA), and another 1–5% develop immune thrombocytopenia (ITP). These aren’t coincidences; the leukemic B cells in CLL dysregulate the immune system in ways that trigger antibody-mediated destruction of the patient’s own red blood cells or platelets.
This means a patient can show up with a positive Coombs test, dropping hemoglobin, and a clinical picture that screams autoimmune — but the underlying driver is a malignancy. If you treat only the autoimmune component without recognizing the leukemia, you’ll miss the real diagnosis.
Other Autoimmune Phenomena Seen in Leukemia
- Pure red cell aplasia — seen in large granular lymphocytic (LGL) leukemia
- Vasculitis and skin lesions — reported in hairy cell leukemia and CLL
- Paraneoplastic pemphigus — a rare but serious blistering condition associated with CLL
- Evans syndrome (simultaneous AIHA + ITP) — occurs in up to 3% of CLL cases
- Autoimmune neutropenia — less common but documented in several leukemia subtypes
Can Autoimmune Diseases Cause Leukemia?
Not directly, but there’s epidemiological data suggesting a link. A large Swedish population-based study published in Blood found that patients with certain autoimmune conditions — including rheumatoid arthritis, SLE, and autoimmune hemolytic anemia — had a modestly elevated risk of developing lymphoid malignancies, including CLL and non-Hodgkin lymphoma. The relative risk was generally in the range of 1.5–2.5x compared to the general population.
The mechanism likely involves chronic immune stimulation. When the immune system stays activated for years or decades, the constant proliferation of lymphocytes increases the chance of acquiring oncogenic mutations. Additionally, some immunosuppressive drugs used to treat autoimmune conditions (like azathioprine and cyclophosphamide) carry their own small risk of secondary malignancy.
Overlapping Symptoms That Cause Confusion
One reason patients search “is leukemia an autoimmune disease” is that early symptoms of both can be virtually identical. Consider this overlap:
- Fatigue — present in nearly all autoimmune diseases and nearly all leukemias
- Unexplained fevers — common in lupus flares and in leukemia (especially acute forms)
- Joint and bone pain — seen in rheumatoid arthritis but also in acute lymphoblastic leukemia (ALL), especially in children
- Low blood counts (cytopenias) — lupus can cause pancytopenia; so can leukemia
- Enlarged lymph nodes — found in Sjögren’s syndrome and CLL alike
This is why a complete blood count with differential, peripheral blood smear, and — when indicated — a bone marrow biopsy are essential. An ANA panel and autoimmune workup might be entirely normal in leukemia, while a peripheral smear might show circulating blasts that no autoimmune disease would explain.
When to See a Doctor
If you’ve been diagnosed with an autoimmune condition but your blood counts keep worsening despite treatment, or if you develop new cytopenias that don’t fit the expected pattern of your autoimmune disease, ask your doctor specifically about the possibility of an underlying hematologic malignancy.
Red flags that warrant urgent hematology evaluation:
- White blood cell count persistently above 15,000/µL or below 2,000/µL without clear explanation
- Unexplained lymphocytosis (absolute lymphocyte count >5,000/µL in adults)
- Progressive anemia or thrombocytopenia that doesn’t respond to standard autoimmune therapy
- Palpable splenomegaly or rapidly growing lymph nodes
- Night sweats, unintentional weight loss >10% body weight, or drenching fevers
Key Takeaways
- Leukemia is a cancer, not an autoimmune disease — they are fundamentally different at the cellular level.
- However, leukemia (especially CLL) frequently causes autoimmune complications like AIHA and ITP.
- Chronic autoimmune diseases may slightly increase the risk of developing certain leukemias over time.
- Symptom overlap between the two is significant, making careful diagnostic workup critical.
- If autoimmune treatment isn’t working as expected, consider asking about hematologic malignancy.
Frequently Asked Questions
Can leukemia be misdiagnosed as an autoimmune disease?
Yes, and it happens more often than you’d think. CLL presenting primarily with autoimmune hemolytic anemia can initially be treated as a standalone autoimmune condition, delaying the leukemia diagnosis by months. Children with ALL sometimes receive initial referrals to rheumatology for joint pain before blood work reveals blasts. Any atypical autoimmune presentation — especially with abnormal CBC findings — should prompt consideration of malignancy.
Does having lupus increase my risk of leukemia?
Slightly. Population studies suggest SLE patients have approximately a 2–3x increased risk of developing non-Hodgkin lymphoma and a modestly increased risk of leukemia compared to the general population. However, the absolute risk remains low. Much of this risk may relate to chronic immune activation and long-term immunosuppressive therapy rather than lupus itself.
Why does CLL cause autoimmune problems so often?
CLL is a malignancy of B lymphocytes — the very cells responsible for producing antibodies. When these cells become malignant, they disrupt normal immune regulation, leading to the production of autoantibodies against the patient’s own blood cells. The malignant CLL cells also alter T-cell function and cytokine signaling, creating an environment ripe for autoimmune complications.
If I have autoimmune hemolytic anemia, should I be screened for leukemia?
Your doctor should always evaluate for an underlying cause when AIHA is diagnosed, especially in adults over 50. A peripheral blood smear and flow cytometry are reasonable screening steps. About 10–15% of adults with warm AIHA have an underlying lymphoproliferative disorder like CLL. In children, isolated AIHA is more likely to be primary, but persistent or recurrent cases still warrant further investigation.
Can treating the leukemia resolve the autoimmune symptoms?
Often, yes. In CLL-associated AIHA or ITP, treating the underlying leukemia with agents like rituximab, ibrutinib, or other CLL-directed therapies frequently resolves the autoimmune complications. In some cases, the autoimmune manifestation itself becomes the indication to start CLL treatment, even if the leukemia would otherwise be managed with watch-and-wait.